These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36648008)

  • 1. Evaluating the cost of managing patients with cellulitis in Wales, UK: A 20-year population-scale study.
    Humphreys I; Akbari A; Griffiths R; Graham-Woollard D; Morgan K; Noble-Jones R; Gabe-Walters M; Thomas M
    Int Wound J; 2023 Aug; 20(6):2129-2140. PubMed ID: 36648008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of managing patients with venous leg ulcers.
    Phillips CJ; Humphreys I; Thayer D; Elmessary M; Collins H; Roberts C; Naik G; Harding K
    Int Wound J; 2020 Aug; 17(4):1074-1082. PubMed ID: 32383324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the costs associated with the management of patients with chronic wounds using linked routine data.
    Phillips CJ; Humphreys I; Fletcher J; Harding K; Chamberlain G; Macey S
    Int Wound J; 2016 Dec; 13(6):1193-1197. PubMed ID: 25818405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study.
    Gould DW; Doidge J; Sadique MZ; Borthwick M; Hatch R; Caskey FJ; Forni L; Lawrence RF; MacEwen C; Ostermann M; Mouncey PR; Harrison DA; Rowan KM; Young JD; Watkinson PJ
    Health Technol Assess; 2022 Feb; 26(13):1-58. PubMed ID: 35212260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare and wider societal implications of stillbirth: a population-based cost-of-illness study.
    Campbell HE; Kurinczuk JJ; Heazell A; Leal J; Rivero-Arias O
    BJOG; 2018 Jan; 125(2):108-117. PubMed ID: 29034559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current costs of dialysis modalities: A comprehensive analysis within the United Kingdom.
    Roberts G; Holmes J; Williams G; Chess J; Hartfiel N; Charles JM; McLauglin L; Noyes J; Edwards RT
    Perit Dial Int; 2022 Nov; 42(6):578-584. PubMed ID: 35068280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac interventions in Wales: A comparison of benefits between NHS Wales specialties.
    Davies G; Akbari A; Bailey R; Evans L; Smith K; Goodfellow J; Thomas M; Lutchman Singh K
    PLoS One; 2024; 19(2):e0297049. PubMed ID: 38335178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The direct cost of intravenous insulin infusions to the NHS in England and Wales.
    Rajendran R; Scott A; Rayman G
    Clin Med (Lond); 2015 Aug; 15(4):330-3. PubMed ID: 26407380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The costs of epilepsy misdiagnosis in England and Wales.
    Juarez-Garcia A; Stokes T; Shaw B; Camosso-Stefinovic J; Baker R
    Seizure; 2006 Dec; 15(8):598-605. PubMed ID: 17011217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology, healthcare and societal burden of basal cell carcinoma in Wales 2000-2018: a retrospective nationwide analysis.
    Ibrahim N; Jovic M; Ali S; Williams N; Gibson JAG; Griffiths R; Dobbs TD; Akbari A; Lyons RA; Hutchings HA; Whitaker IS
    Br J Dermatol; 2023 Feb; 188(3):380-389. PubMed ID: 36715329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales.
    McGuire A; Irwin DE; Fenn P; Gray A; Anderson P; Lovering A; MacGowan A
    Value Health; 2001; 4(5):370-5. PubMed ID: 11705127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of health inequality to the NHS in Wales.
    Kadel R; Allen J; Darlington O; Masters R; Collins B; Charles JM; Asaria M; Dyakova M; Bellis M; Cookson R
    Front Public Health; 2022; 10():959283. PubMed ID: 36187677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunity costs and local health service spending decisions: a qualitative study from Wales.
    Karlsberg Schaffer S; Sussex J; Hughes D; Devlin N
    BMC Health Serv Res; 2016 Mar; 16():103. PubMed ID: 27012523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green-blue space exposure changes and impact on individual-level well-being and mental health: a population-wide dynamic longitudinal panel study with linked survey data.
    Geary RS; Thompson DA; Garrett JK; Mizen A; Rowney FM; Song J; White MP; Lovell R; Watkins A; Lyons RA; Williams S; Stratton G; Akbari A; Parker SC; Nieuwenhuijsen MJ; White J; Wheeler BW; Fry R; Tsimpida D; Rodgers SE
    Public Health Res (Southampt); 2023 Oct; 11(10):1-176. PubMed ID: 37929711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the incidence, prevalence and true cost of asthma in the UK: secondary analysis of national stand-alone and linked databases in England, Northern Ireland, Scotland and Wales-a study protocol.
    Mukherjee M; Gupta R; Farr A; Heaven M; Stoddart A; Nwaru BI; Fitzsimmons D; Chamberlain G; Bandyopadhyay A; Fischbacher C; Dibben C; Shields M; Phillips C; Strachan D; Davies G; McKinstry B; Sheikh A;
    BMJ Open; 2014 Nov; 4(11):e006647. PubMed ID: 25371419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.
    Connock M; Burls A; Frew E; Fry-Smith A; Juarez-Garcia A; McCabe C; Wailoo A; Abrams K; Cooper N; Sutton A; O'Hagan A; Moore D
    Health Technol Assess; 2006 Jul; 10(24):iii-iv, ix-136. PubMed ID: 16796930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported outcome measures for monitoring primary care patients with depression: the PROMDEP cluster RCT and economic evaluation.
    Kendrick T; Dowrick C; Lewis G; Moore M; Leydon GM; Geraghty AW; Griffiths G; Zhu S; Yao GL; May C; Gabbay M; Dewar-Haggart R; Williams S; Bui L; Thompson N; Bridewell L; Trapasso E; Patel T; McCarthy M; Khan N; Page H; Corcoran E; Hahn JS; Bird M; Logan MX; Ching BCF; Tiwari R; Hunt A; Stuart B
    Health Technol Assess; 2024 Mar; 28(17):1-95. PubMed ID: 38551155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the economic impact of a national lymphoedema service in Wales.
    Humphreys I; Thomas MJ
    Br J Nurs; 2017 Nov; 26(20):1093-1100. PubMed ID: 29125341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.